WestVacBiopharmaisfoundedbyAcademicianWeiYuquanfromWestChinaHospitalofSichuanUniversity,togetherwith10scientistsfromStateKeyLaboratoryofBiotherapy(SKLB).ItsheadquarterislocatedintheInternationalBio-Town,Chengdu.TheCEOofWestVacBiopharmaisProf.WeiYuquan,whoistheAcademicianofChineseAcademyofSciencesaswellastheDirectorofStateKeyLaboratoryofBiotherapy.WestVaciscommittedtoexploringthelatestbiotherapytechnologiesformajordiseases,includinginfectiousdiseases,malignanttumors,cardiovasculardiseases,andsoon.IthasattachedgreatimportanceintheResearchandDevelopment(R&D)ofCOVID-19vaccineespeciallyandbuildingaCOVID-19vaccineproductionplatform.StateKeyLaboratoryofBiotherapy(SKLB)wasestablishedbytheMinistryofSciencesandTechnologyofChinain2005andbecameoneoftheNationalR&DPlatformsforNovelDrugsfoundedbytheMinistriesofSciencesandTechnologyaswellasthatofHealthofChinain2008.ItisalsosupportedbyNationalCollaborativeInnovationProgramandhasbecometheNationalCollaborativeInnovationCenterforBiotherapysince2013.WestChinaHospitalofSichuanUniversity，foundedin1892,istheNationalCenterforDiagnosisandTreatmentofSevereandCriticalDiseasesinWesternChina.Itisalsotheworld’slargestcomprehensivehospitalcomplexlocatedinonecampusarea.RelyingonthemedicalresourcesofStateKeyLaboratoryofBiotherapyandWestChinaMedicalCenter,WestVachasadoptedrecombinantproteinmethodologytodeveloptheCOVID-19vaccine.Becauseofthesafetyoftheproteinvaccine,itisalsotheonlyCOVID-19vaccineapprovedfortheuseinchildrenover3yearsoldinChina.ThevaccinewasapprovedbytheNationalMedicalProductsAdministrationforclinicaltrialsonAugust21,2020.PhaseI/IIclinicaltrialshavebeencompleted,andphaseIIIclinicaltrialsarebeingcarriedoutinNepal,Kenya,Japanandothercountries.Thevaccinetargetsthespikeproteinbindingdomain(S-RBD)ofSARS-CoV-2,producingneutralizingantibodiestoblockCOVID-19infectionofhumancells.TheresultwaspublishedonNature,theworld’sfamousscientificjournalonJuly29th,2020.IthasalsobeenthefirstpaperofCOVIDvaccinepublishedbyNaturesincethepandemicoutbreak.TheS-RBDgeneoftheCOVID-19virusisintroducedintotheinsectcells,whichwereusedasafactorytoproducehigh-qualityrecombinantvaccineproteinandthendoesrefinedpurification.Suchtechnologyiseasytobemass-producedandbroughttothemarket.WestVacBiopharmaiscommittedtobecomingtheworld`sleadingvaccineandimmunotherapyplatform.
更新时间：2025-07-11 直达：westvacpharma.com
徐州烨途宠物用品有限公司致力于攻克猫咪的各种传染性疾病,对猫传腹治疗效率高,产品主要对于湿性猫传腹,干式猫传腹,猫传腹症状,猫传腹早期症状有较大的帮助,面向全国进行销售,欢迎全国经销商前来咨询洽谈!
更新时间：2025-06-27 直达：www.maochuanfu.com
昆山房产网是致力于昆山地区的专业房地产信息网，是集昆山新楼盘报名、昆山二手房信息、昆山出租房信息、昆山小区大全、昆山房产中介信息等的房产信息网。
中图网（原中国图书网）：网上书店，创办于1998年，通过好书推荐、畅销书、淘书团、特色专题等栏目及各种促销活动，致力于为读者提供价廉物美的正版优质书籍，是爱书人的淘书圣地。
暂无描述...
由产业界采购及供应商管理资深团队创立,航空航天产业链供应链专业服务商,公司研发与运营的航空产业网™,为客户提供信息、技术与渠道的一站式专业服务,已通过中国商飞、中航西飞等主制造商的供应商认证，是世界最大的航空航天第三方认证机构法国必维（BureauVeritas）集团航空航天领域在华唯一战略合作单位,航空工业集团总部课题承担单位
暂无描述...
暂无描述...
植物大全,植物百科,养花知识,农林牧渔
暂无描述...
北京泰科诺科技有限公司成立于2003年，一直专注于真空薄膜新材料沉积设备、真空技术应用设备及其工艺的研发试制生产,是一家集研发、设计、制浩销售和服务于一体的高新技术企业，在行业内独树一帜。 公司拥有一支由多位教授、博士等领衔的技术研发、顾问团队，具有较强的自主研发能力，确保了真空设备产品的高水平。同时建有研发镀膜工艺、服务客户的开放实验室，始终保持技术领先优势，且拥有多项真空专利技术。